Stock GMT GENOMTEC S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Company Genomtec S.A.

Equities

GMT

PLGNMTC00017

Biotechnology & Medical Research

Market Closed - Warsaw S.E.
Other stock markets
 12:07:26 2024-06-21 EDT 		5-day change 1st Jan Change
11.1 PLN -0.89% Intraday chart for Genomtec S.A. -2.46% +2.30%
05-29 Genomtec S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-25 Genomtec S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Genomtec SA is a Poland-based company engaged in biotechnology and medical research business sector and it is operating in the field of clinical diagnostics. The Company is focused on development of of Genomtec ID, a mobile platform for genetic diagnosis in the point of patient care. Its creation and commercialization allows the diagnostic process to be executed in point of care setting, such as: primary care clinics, pharmacies, doctor’s offices, hospital emergency departments (ERs) without the need for complicated and time-consuming laboratory workflow conducted by qualified personnel.

Number of employees: 17

Sales per Business

PLN in Million2022Weight2023Weight Delta
Biotechnology
100.0 %
0 100.0 % 0 100.0 % -97.50%

Sales per region

PLN in Million2022Weight2023Weight Delta
Poland
100.0 %
0 100.0 % 0 100.0 % -97.50%

Managers

Managers TitleAgeSince
Henryk Roguszczak FOU
 Founder - 16-11-21
Malgorzata Malodobra FOU
 Founder - -
Miron Tokarski CEO
 Chief Executive Officer - 16-11-21
Michal Wachowski DFI
 Director of Finance/CFO - -
Richard Moore CTO
 Chief Tech/Sci/R&D Officer - -
Jaroslaw Oleszczuk BRD
 Director/Board Member 50 -
Boleslaw Winiarski PRN
 Corporate Officer/Principal - -
Sebastian Wojciech Lekawa PRN
 Corporate Officer/Principal 46 -

Members of the board

Members of the board TitleAgeSince
Krzysztof Piotr Krawczyk BRD
 Director/Board Member 48 19-12-31
Jakub Swadzba BRD
 Director/Board Member - -
Karol Hop CHM
 Chairman 35 -
Jaroslaw Oleszczuk BRD
 Director/Board Member 50 -
Michal Jank BRD
 Director/Board Member - -
Tomasz Jurek BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 12,257,886 9,251,148 ( 75.47 %) 0 75.47 %

Company contact information

Genomtec SA

ul. Stablowicka 147 Port Budynek 2

54-066, Wroclaw

+48 793 440 931

http://www.genomtec.com
address Genomtec S.A.(GMT)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
GENOMTEC S.A. Stock Genomtec S.A.
+2.30% 36.51M
MODERNA, INC. Stock Moderna, Inc.
+34.14% 51.12B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-6.54% 39.4B
LONZA GROUP AG Stock Lonza Group AG
+34.92% 38.48B
CELLTRION, INC. Stock Celltrion, Inc.
-12.11% 26.22B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+12.62% 26.36B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-13.43% 20.96B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+43.73% 14.02B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+31.81% 12.49B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-4.54% 11.61B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. GMT Stock
  4. Company Genomtec S.A.